¿Cuál es la fisiopatología de la sífilis?

Respuesta generada por Itaca · 24 fuentes · 30 de julio de 2026

Pregunta original

Fisio patología de sífilis como ets

Summary

Syphilis is a systemic sexually transmitted infection caused by the spirochete Treponema pallidum subsp. pallidum. It enters through microscopic breaks in skin or mucosa, disseminates early through lymphatic and hematogenous routes, and produces disease largely through the host inflammatory response rather than direct toxin-mediated injury.[1,2] Its clinical course is classically divided into primary, secondary, latent, and tertiary stages, although stages may overlap and manifestations can be atypical. Untreated infection can persist for years and cause neurologic, ocular, cardiovascular, and other organ disease.

Pathophysiology

1. Entry and local infection

Transmission usually occurs through direct contact with infectious lesions during vaginal, anal, or oral sex. The organism penetrates mucous membranes or microscopic epithelial abrasions; transmission can occur even when lesions are not recognized clinically.[2,3] The incubation period is typically approximately 3 weeks, with a reported range of 10–90 days.[1]

At the inoculation site, T. pallidum adheres to epithelial, extracellular-matrix, and endothelial structures. It has unusual motility and tissue-invasive capacity, allowing it to cross tissue planes and enter lymphatic and vascular channels. The organism does not depend on a classical exotoxin for tissue injury; local pathology is predominantly inflammatory.[1,4]

2. Early dissemination

Syphilis should be considered systemic from an early point in infection. Spirochetes can disseminate through lymphatics and blood before the primary lesion becomes clinically evident, potentially reaching the central nervous system, eyes, placenta, and other tissues.[2,4]

The organism’s low abundance of exposed outer-membrane proteins helps it evade antibody-mediated recognition. Additional mechanisms include antigenic variation and persistence in relatively immune-privileged sites. These properties contribute to chronic infection, latent periods, and the possibility of reinfection after treatment because natural infection does not reliably provide protective immunity.[1,5]

3. Immune response and tissue injury

The primary lesion is produced by a cellular inflammatory response, classically with a perivascular infiltrate containing plasma cells, lymphocytes, and macrophages. Endothelial activation and vascular inflammation are important features. The lesion typically evolves into a firm, painless ulcer—the chancre—with regional lymphadenopathy; it may resolve spontaneously despite persistence of the organism.[2,4]

In secondary syphilis, systemic dissemination and a broader immune response produce diffuse mucocutaneous disease, including rash, mucous patches, and condylomata lata. The rash may involve the palms and soles. Histologically, vascular inflammation and plasma-cell-rich infiltrates are common, but clinical findings are variable, which accounts for the term “great imitator.”[3,6]

The inflammatory response may partially reduce the organism burden without eradicating infection. This explains why clinical lesions can disappear while viable organisms remain and why the disease can enter a latent phase. The precise immunologic mechanisms are incompletely defined; evidence supports both pathogen immune evasion and incomplete or dysregulated host clearance.[1,5]

Clinical stages as a pathophysiologic sequence

  • Primary syphilis: local inoculation lesion with regional lymphatic involvement; usually a painless chancre.
  • Secondary syphilis: hematogenous dissemination with systemic and mucocutaneous inflammation.
  • Latent syphilis: serologic evidence of infection without clinical manifestations. Sexual transmission is much less likely in latent disease, but reactivation or progression can occur if untreated.[2]
  • Tertiary syphilis: delayed inflammatory and fibrotic injury, which may manifest as gummas, aortitis—including aortic-root disease—and neurologic involvement. Tertiary disease generally reflects long-term host–pathogen interaction rather than continuous high-level bacteremia.[1,6]

Neurosyphilis and ocular syphilis

Central nervous system invasion can occur early, even in patients without neurologic symptoms. Neurosyphilis may present at any stage, with manifestations ranging from meningitis and cranial neuropathies to stroke, tabes dorsalis, or cognitive decline. Ocular syphilis can affect virtually any ocular structure and should be managed as a potentially vision-threatening manifestation.[3]

Congenital transmission

During pregnancy, T. pallidum can cross the placenta through hematogenous dissemination from the infected mother to the fetus. Fetal infection can result in miscarriage, stillbirth, hydrops, prematurity, neonatal disease, or later manifestations involving the teeth, bones, hearing, vision, and nervous system. The risk is highest in untreated early maternal infection but is not eliminated in later stages.[4]

Clinical implications

The absence of a chancre or rash does not exclude infection. Diagnosis generally requires both a treponemal test and a quantitative nontreponemal test such as RPR or VDRL, interpreted with the clinical history; a single test type is insufficient in many situations.[1] Any neurologic, ocular, or otologic symptoms require targeted evaluation, and pregnancy requires prompt testing and treatment because penicillin is the established therapy for preventing congenital syphilis.[8,9] Adequate treatment does not prevent future reinfection, so sexual partners and ongoing risk should be assessed.

Fuentes

  1. https://www.cdc.gov/std/syphilis/syphilis-pocket-guide-final-508.pdf
  2. https://platform.who.int/docs/default-source/mca-documents/policy-documents/guideline/LKA-RH-43-01-GUIDELINE-2011-eng-National-Guidelines-for-the-manageemnt-of-maternal-syphilis-and-Congenital-syphilis.pdf
  3. https://www.cdc.gov/std/treatment-guidelines/latent-syphilis.htm
  4. https://stacks.cdc.gov/view/cdc/42437/cdc_42437_DS1.pdf
  5. https://www.who.int/news-room/fact-sheets/detail/syphilis
  6. https://www.who.int/es/news-room/fact-sheets/detail/syphilis
  7. https://www.who.int/teams/global-hiv-hepatitis-and-stis-programmes/stis/prevention/mother-to-child-transmission-of-syphilis
  8. https://louisianahealthhub.org/wp-content/uploads/2018/11/Syphilis-Treatment.pdf
  9. https://npin.cdc.gov/publication/praxis-medical-insights-syphilis-diagnosis-and-management
  10. https://iris.who.int/bitstream/handle/10665/43782/9789241595858_eng.pdf
  11. https://www.paho.org/en/topics/syphilis-and-congenital-syphilis
  12. https://www.cdc.gov/mmwr/volumes/73/rr/rr7301a1.htm
  13. https://pubmed.ncbi.nlm.nih.gov/27721440/
  14. https://pubmed.ncbi.nlm.nih.gov/38376088/
  15. https://pubmed.ncbi.nlm.nih.gov/16362988/
  16. https://pubmed.ncbi.nlm.nih.gov/40708500/
  17. https://pubmed.ncbi.nlm.nih.gov/34832520/
  18. https://pmc.ncbi.nlm.nih.gov/articles/PMC12417408/
  19. https://pubmed.ncbi.nlm.nih.gov/29022569/
  20. https://www.ncbi.nlm.nih.gov/books/NBK534780/
  21. https://journals.asm.org/doi/10.1128/cmr.12.2.187
  22. https://pmc.ncbi.nlm.nih.gov/articles/PMC1360276/
  23. https://www.ncbi.nlm.nih.gov/books/NBK7716/
  24. https://emedicine.medscape.com/article/229461-overview

Respuesta generada por inteligencia artificial a partir de las fuentes citadas. Verifica las fuentes antes de aplicarla.

¿Tienes una pregunta sobre tu propio caso? Itaca responde con fuentes en segundos.

Hacer una pregunta

Más preguntas sobre sífilis